×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AURA – aura biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AURA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/14
08:15 am
aura
Aura Biosciences, Inc. (NASDAQ: AURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Medium
Report
Aura Biosciences, Inc. (NASDAQ: AURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
11/12
04:05 pm
aura
Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights
Medium
Report
Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights
10/21
03:13 pm
aura
Aura Biosciences: 2 Positive Bel-Sar Data Releases Brings Shareholder Value [Seeking Alpha]
Neutral
Report
Aura Biosciences: 2 Positive Bel-Sar Data Releases Brings Shareholder Value [Seeking Alpha]
10/18
03:33 pm
aura
Aura Biosciences, Inc. (NASDAQ: AURA) had its "buy" rating re-affirmed by analysts at Cowen Inc.
Low
Report
Aura Biosciences, Inc. (NASDAQ: AURA) had its "buy" rating re-affirmed by analysts at Cowen Inc.
10/18
11:53 am
aura
Aura Biosciences, Inc. (NASDAQ: AURA) had its price target raised by analysts at Scotiabank from $20.00 to $23.00. They now have a "sector outperform" rating on the stock.
Low
Report
Aura Biosciences, Inc. (NASDAQ: AURA) had its price target raised by analysts at Scotiabank from $20.00 to $23.00. They now have a "sector outperform" rating on the stock.
10/18
11:01 am
aura
Aura Biosciences, Inc. (NASDAQ: AURA) had its price target raised by analysts at BTIG Research from $21.00 to $24.00. They now have a "buy" rating on the stock.
Low
Report
Aura Biosciences, Inc. (NASDAQ: AURA) had its price target raised by analysts at BTIG Research from $21.00 to $24.00. They now have a "buy" rating on the stock.
10/18
08:33 am
aura
Aura Biosciences, Inc. (NASDAQ: AURA) had its price target raised by analysts at HC Wainwright from $21.00 to $22.00. They now have a "buy" rating on the stock.
Low
Report
Aura Biosciences, Inc. (NASDAQ: AURA) had its price target raised by analysts at HC Wainwright from $21.00 to $22.00. They now have a "buy" rating on the stock.
10/17
04:05 pm
aura
Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial
High
Report
Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial
Date
Time
Action
From
To
Firm
Impact
%Chg
9/13
07:15 am
Maintains
Market Outperform
Market Outperform
JMP Securities
Medium
Report
5.6%
Date
Time
Symbol
Headline
Impact
11/18
09:07 pm
aura
Form 4 Aura Biosciences, Inc. For: Nov 18 Filed by: Hopkins Janet Jill
Low
Report
Form 4 Aura Biosciences, Inc. For: Nov 18 Filed by: Hopkins Janet Jill
11/18
07:33 pm
aura
Form 144 Aura Biosciences, Inc. Filed by: Hopkins Janet Jill
Low
Report
Form 144 Aura Biosciences, Inc. Filed by: Hopkins Janet Jill
11/14
05:51 pm
aura
Form SC 13G/A Aura Biosciences, Inc. Filed by: Lundbeckfond Invest A/S
Medium
Report
Form SC 13G/A Aura Biosciences, Inc. Filed by: Lundbeckfond Invest A/S
11/14
04:19 pm
aura
Form SC 13G/A Aura Biosciences, Inc. Filed by: CITADEL ADVISORS LLC
Medium
Report
Form SC 13G/A Aura Biosciences, Inc. Filed by: CITADEL ADVISORS LLC
11/12
04:16 pm
aura
Form 10-Q Aura Biosciences, Inc. For: Sep 30
Medium
Report
Form 10-Q Aura Biosciences, Inc. For: Sep 30
11/12
04:11 pm
aura
Form 8-K Aura Biosciences, Inc. For: Nov 12
Medium
Report
Form 8-K Aura Biosciences, Inc. For: Nov 12
11/12
09:37 am
aura
Form SC 13G/A Aura Biosciences, Inc. Filed by: Adage Capital Management, L.P.
Medium
Report
Form SC 13G/A Aura Biosciences, Inc. Filed by: Adage Capital Management, L.P.
11/8
02:18 pm
aura
Form SC 13G Aura Biosciences, Inc. Filed by: BlackRock, Inc.
Low
Report
Form SC 13G Aura Biosciences, Inc. Filed by: BlackRock, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: